Dr. Amaria on Genetically Modified TILs in Melanoma
1 Mga view
administrator
07/03/23
Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.
Magpakita ng higit pa
Mga Komento sa Facebook
Walang nakitang komento